226 related articles for article (PubMed ID: 21801427)
1. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.
Takikita M; Xie R; Chung JY; Cho H; Ylaya K; Hong SM; Moskaluk CA; Hewitt SM
J Transl Med; 2011 Jul; 9():126. PubMed ID: 21801427
[TBL] [Abstract][Full Text] [Related]
2. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies.
Pollock NI; Wang L; Wallweber G; Gooding WE; Huang W; Chenna A; Winslow J; Sen M; DeGrave KA; Li H; Zeng Y; Grandis JR
Clin Cancer Res; 2015 Oct; 21(20):4597-606. PubMed ID: 26138066
[TBL] [Abstract][Full Text] [Related]
4. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
5. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
Clauditz TS; von Rheinbaben K; Lebok P; Minner S; Tachezy M; Borgmann K; Knecht R; Sauter G; Wilczak W; Blessmann M; Münscher A
Pathol Res Pract; 2014 Oct; 210(10):649-55. PubMed ID: 25028217
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
[TBL] [Abstract][Full Text] [Related]
7. HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin AR; Rossi M; Patel M; El-Deiry M; Wadsworth JT; Chen Z; Khuri FR; Shin DM; Saba NF; Chen ZG
Clin Cancer Res; 2017 Feb; 23(3):677-686. PubMed ID: 27358485
[TBL] [Abstract][Full Text] [Related]
8. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
[TBL] [Abstract][Full Text] [Related]
9. HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated.
Sardari Y; Pardis S; Tadbir AA; Ashraf MJ; Fattahi MJ; Ebrahimi H; Purshahidi S; Khademi B; Hamzavi M
Asian Pac J Cancer Prev; 2012; 13(6):2891-6. PubMed ID: 22938479
[TBL] [Abstract][Full Text] [Related]
10. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
12. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
13. HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.
Lee HJ; Chung JY; Hewitt SM; Yu E; Hong SM
Virchows Arch; 2012 Nov; 461(5):521-30. PubMed ID: 23052372
[TBL] [Abstract][Full Text] [Related]
14. Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
Berghoff AS; Bartsch R; Preusser M; Ricken G; Steger GG; Bago-Horvath Z; Rudas M; Streubel B; Dubsky P; Gnant M; Fitzal F; Zielinski CC; Birner P
Breast; 2014 Oct; 23(5):637-43. PubMed ID: 25017122
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
16. Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
Aigelsreiter AM; Aigelsreiter A; Wehrschuetz M; Ress AL; Koller K; Salzwimmer M; Gerger A; Schauer S; Bauernhofer T; Pichler M
Hum Pathol; 2014 Apr; 45(4):683-90. PubMed ID: 24565202
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
[TBL] [Abstract][Full Text] [Related]
18. Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma.
Almadori G; Coli A; De Corso E; Mele DA; Settimi S; Di Cintio G; Brigato F; Scannone D; Carey TE; Paludetti G; Lauriola L; Ranelletti FO
J Transl Med; 2021 Sep; 19(1):408. PubMed ID: 34579737
[TBL] [Abstract][Full Text] [Related]
19. High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck.
Shames DS; Carbon J; Walter K; Jubb AM; Kozlowski C; Januario T; Do A; Fu L; Xiao Y; Raja R; Jiang B; Malekafzali A; Stern H; Settleman J; Wilson TR; Hampton GM; Yauch RL; Pirzkall A; Amler LC
PLoS One; 2013; 8(2):e56765. PubMed ID: 23468880
[TBL] [Abstract][Full Text] [Related]
20. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]